PHASE-3 STUDIES WITH ETOPOSIDE (VP16-213) IN LUNG-CANCER PATIENTS

被引：0
作者：
ISSELL, BF [1 ]
ROSENBAUM, PF [1 ]
DHAFIR, RA [1 ]
机构：
[1] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 7卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
[31]   VERAPAMIL ENHANCES THE SENSITIVITY TO ADRIAMYCIN AND VP16-213 OF HUMAN-LUNG CANCER INVITRO [J].
FETHERSTON, CA ;
MERRY, S ;
KAYE, SB ;
FRESHNEY, RI .
BRITISH JOURNAL OF CANCER, 1985, 51 (04) :598-599
[32]   VP-16-213 VERSUS POLYCHEMOTHERAPY IN PATIENTS WITH ADVANCED SMALL CELL LUNG-CANCER [J].
EAGAN, RT ;
CARR, DT ;
FRYTAK, S ;
RUBIN, J ;
LEE, RE .
CANCER TREATMENT REPORTS, 1976, 60 (07) :949-951
[33]   ETOPOSIDE (VP16-213) - A PODOPHYLLOTOXIN-DERIVATIVE WITH HIGH ANTI-TUMOR ACTIVITY [J].
SCHMOLL, HJ ;
NIEDERLE, N ;
ACHTERRATH, W .
KLINISCHE WOCHENSCHRIFT, 1981, 59 (21) :1177-1188
[34]   VP16-213 AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY [J].
ESTAPE, J ;
CIRERA, L ;
MILLA, A ;
DONCEL, F .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) :154-157
[35]   PHARMACOKINETICS OF ETOPOSIDE (VP) IN PATIENTS WITH SMALL CELL LUNG-CANCER [J].
EDMUNDSON, J ;
THATCHER, N ;
WILKINSON, PM ;
MARGISON, J ;
STEWARD, W ;
CHIU, W ;
WAGSTAFFE, J .
BRITISH JOURNAL OF CANCER, 1983, 48 (01) :114-114
[36]   DRUG-MONITORING OF ETOPOSIDE (VP16-213) CORRELATION OF PHARMACOKINETIC PARAMETERS TO CLINICAL AND BIOCHEMICAL DATA FROM PATIENTS RECEIVING ETOPOSIDE [J].
PFLUGER, KH ;
SCHMIDT, L ;
MERKEL, M ;
JUNGCLAS, H ;
HAVEMANN, K .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (01) :59-66
[37]   PHARMACOKINETICS OF VP16-213 IN LEWIS LUNG-CARCINOMA BEARING MICE [J].
COLOMBO, T ;
BROGGINI, M ;
TORTI, L ;
ERBA, E ;
DINCALCI, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :127-131
[38]   COMBINATION CHEMOTHERAPY OF ADVANCED BREAST-CANCER WITH ADRIAMYCIN AND VP16-213 [J].
VANECHO, DA ;
AISNER, J ;
WIERNIK, PH ;
MORRIS, D ;
SERPICK, A .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR) :228-228
[39]   A PHASE-I-II TRIAL OF CONTINUOUS INFUSION VP16-213 [J].
VANECHO, DA ;
AISNER, J ;
WHITACRE, M ;
WIERNIK, PH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :237-238
[40]   VP16-213 AND CIS-DICHLORODIAMMINE PLATINUM (11) (DV) AS INITIAL INDUCTION THERAPY FOR SMALL CELL ANAPLASTIC LUNG-CANCER (SCALC) [J].
BISHOP, JF ;
FOX, R .
MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03) :212-212
12345